Latest News by Industry
INTERCEPT PHARMACEUTICALS, INC. [ICPT] has reported fiscal Q1 loss of $32.10 million.
On a per-share basis, the DE based company said its diluted earnings are $0.77.
The Pharmaceutical Preparations firm posted revenue of $68 million in this period.
Also Read:
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.